Discovery of Potent Anticancer Agent HJC0416, an Orally Bioavailable Small Molecule Inhibitor of Signal Transducer and Activator of Transcription 3 (STAT3)

European Journal of Medicinal Chemistry - France
doi 10.1016/j.ejmech.2014.05.049
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Signal Transducer and Activator of Transcription 3 (STAT3)

Science-Business eXchange
2014English

Signal Transducer and Activator of Transcription 3 (STAT3)

Science-Business eXchange
2014English

Signal Transducer and Activator of Transcription 3 (STAT3)

Science-Business eXchange
2013English

STAT3 (Signal Transducer and Activator of Transcription 3)

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2011English

Signal Transducer and Activator of Transcription-3, Inflammation, and Cancer

Annals of the New York Academy of Sciences
GeneticsMolecular BiologyBiochemistryNeuroscienceHistoryPhilosophy of Science
2009English

Discovery and Evaluation of BMS-708163, a Potent, Selective and Orally Bioavailable Γ-Secretase Inhibitor

ACS Medicinal Chemistry Letters
Organic ChemistryBiochemistryDrug Discovery
2010English

Signal Transducer and Activator of Transcription 3 (Stat3) Expression and Activation in Rat Uterus During Early Pregnancy

Reproduction
Cell BiologyGynecologyEndocrinologyReproductive MedicineObstetricsEmbryology
2004English

Evaluation of Quantitative Assays for the Identification of Direct Signal Transducer and Activator of Transcription 3 (STAT3) Inhibitors

Oncotarget
Oncology
2016English

Signal Transducer and Activator of Transcription 3 (STAT3) Controls Susceptibility to Epstein-Barr Virus Reactivation in B Cells

Infectious Agents and Cancer
Cancer ResearchEpidemiologyOncologyInfectious Diseases
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy